Cooper Companies | الأصول



Assets تغيير تاريخ
Abbott USD 81.41B 7.06B 2024-12
Align Technology USD 6.21B 151.37M 2024-12
AtriCure USD 609.33M 5.74M 2024-12
Avanos Medical USD 1.15B 502M 2024-12
Bausch Health Companies USD 26.54B 45M 2024-09
Baxter International USD 25.78B 894M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Boston Scientific USD 39.4B 1.32B 2024-12
Cooper Companies USD 12.22B 93M 2025-01
Dentsply International USD 5.75B 873M 2024-12
Dexcom USD 6.48B 130.7M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
Haemonetics USD 2.53B 6.05M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
Intuitive Surgical USD 18.74B 999.8M 2024-12
J&J USD 180.1B 1.82B 2024-12
Medtronic USD 89.97B 69M 2025-01
Merit Medical Systems USD 2.42B 40.52M 2024-12
Novartis USD 102.25B 1.28B 2024-12
ResMed USD 7.14B 81.08M 2024-12
STAAR Surgical USD 509.52M 28.07M 2024-12
Steris USD 10.01B 233.78M 2024-12
Stryker USD 42.97B 862M 2024-12
Tandem Diabetes Care USD 967.66M 9.93M 2024-12
Teleflex USD 7.1B 388.38M 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Cooper Companies الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.